The enhancement of melanoma and breast cancer lung metastasis by the VE-cadherin RGD motif highlights the value of cadherin-specific RGD targeting as a novel therapeutic strategy for multiple types of cancer and metastasis. The gene discussed is CDH17; the disease is melanoma.